Brightspring Health Services Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Brightspring Health Services Inc 's ROA in the third quarter of 2026?
Brightspring Health Services Inc achieved a return on average assets (ROA) of 6.54 % in its third quarter of 2026, this is above BTSG's average return on assets of 3.06%.
Brightspring Health Services Inc s assets during the 12 months ending in the third quarter of 2026 are valued at $6 billion

ROA has improved compared to 5.94% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 134 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 1176, from total ROA ranking in the second quarter of 2026 at 1841.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	8.04 %	5.61 %	9.33 %	19.22 %	6.69 %
Y / Y Net Income Change	81.27 %	205.75 %	412.27 %	401.95 %	-
Net Income (TTM) in million	410	365	309	189	127
Return On Assets (TTM)	6.54 %	5.94 %	5.08 %	3.18 %	2.24 %
BTSG's Total Ranking	# 1176	# 1841	# 1820	# 2141	# 2207
Total Assets (TTM) in million	6,365	6,102	6,213	6,413	5,892
Seq. Total Assets Change	4.32 %	-1.79 %	-3.12 %	8.85 %	1.97 %
Seq. Net Income Change	18.92 %	-43.34 %	92.2 %	39.97 %	100.57 %

BTSG's 5 Years Annual ROA >> Back to BTSG Management Effectiveness >> Compare BTSG ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 16
Sector	# 135
Overall	# 939

Return On Assets Statistics
High	Average	Low
6.6 %	3.06 %	-0.36 %
(Sep 30 2026)		(Dec 31 2024)

Financial Statements
Brightspring Health Services Inc 's Assets	$ 6,365 million	BTSG's Balance sheet
Brightspring Health Services Inc 's Income	$ 100 million	Quarterly BTSG's Income Statement
BTSG's Income by Division		See BTSG's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	FY	FY	FY
Y / Y Total Assets Change	13.04 %	-	-	-	-
Total Assets in million	6,413	5,673	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	189	-21	0	0	0
Annual Return On Assets	2.95 %	-0.36 %	-	-	-

BTSG's 5 Years Annual ROA >> Back to BTSG Management Effectiveness >> Compare BTSG ROA to its Competitors

Comment on BTSG's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 2.95 % compared to prior year, due to annual net income growth of % to $189.11 million, while value of Brightspring Health Services Inc 's overall assets grew just by 13.04 % to $6,413.31 million, compared to $6,413.31 a year before.

More Return On Assets Ratios
BTSG's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BTSG's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BTSG's Competitors
Subscribers only: Roa for Brightspring Health Services Inc 's Suppliers
Subscribers only: Return On Assets for BTSG's Customers

You may also want to know
BTSG's Roi	BTSG's Inventory Turnover Ratio	BTSG's Growth Rates	BTSG's Dividend Comparisons
	BTSG's Profitability Ratios	BTSG's Asset Turnover Ratio	BTSG's Dividend Growth
BTSG's Roe	BTSG's Valuation Ratios	BTSG's Financial Strength Ratios	BTSG's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Beone Medicines Ltd	10.23 %
Amgen Inc	10.02 %
Bio rad Laboratories Inc	9.88 %
3m Company	9.60 %
Bioventus Inc	9.47 %
Medinotec Inc	8.67 %

Date modified: 2026-10-31T17:31:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.